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Abstract
Background: laparoscopic adrenalectomy has become the standard treatment for adrenal lesions. The better
clinical outcoms of laparoscopic technique are valid for treatment of small benign masses (< 5–6 cm), instead
there are still open questions in literature regarding the correct management of larger lesions (> 6 cm) or in case of
potentially malignant adrenal tumors. The aim of this study is to evaluate the outcomes of laparoscopic adrenalectomy
in a referral surgical department for endocrine surgery.
Methods: at the University Hospital Policlinico “P. Giaccone” of Palermo between January 2010 and December 2017
we performed a total of 81 laparoscopic adrenalectomy. We created a retrospective database with analysis of patients
data, morphologic and hormonal characteristics of adrenal lesions, surgical procedures and postoperative results with
histological diagnosis and complications.
Results: Mean size of adrenal neoplasm was 7,5 cm (range 1.5 to 18 cm). The mean operative time was 145min (range
75–240). In statistical analysis lenght of surgery was correlated to the lesion diameter (p < 0.05) but not with
pre-operative features or histological results. 5 intraoperative complications occurred. Among these patients 4
presented bleeding and 1 a diaphagmatic lesion. No conversion to open surgery was necessary and no intraoperative
blood transfusion were required. Mean estimated blood loss was 95 ml (range 50–350). There was no capsular
disruption during adrenal dissection. Mean length of hospital stay was 3.7 days (range 3–6 days).
Conclusions: Laparoscopic adrenalectomy is a safe procedure with low rate of morbidity. An accurate preoperative
radiological examination is fundamental to obtain a stringent patients selection. The lesion diameter is related
to longer operative time and appeares as the main predictive parameter of intraoperative complications but
these results are not statistically significant. On the other side secreting adrenal tumors require more attention
in operative management without increased rate of postoperative complications.
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Background
Since first description in 1992 by Gagner laparoscopic
adrenalectomy (LA) has become the standard treat-
ment for adrenal lesions [1]. Over the years several
studies have identified the advantages of laparoscopic
technique with reduction in morbidity and periopera-
tive mortality due to less operative blood loss, lower
complication rates, less postoperative pain, shorter
hospital stay and better cosmetic results when compared
with open adrenalectomy (OA) [2]. On the basis of positive
outcomes of LA performed with traditional lateral trans-
peritoneal approach, other surgical techniques have also
been developed as posterior retroperitoneoscopic adrenal-
ectomy (PRA) or robotic adrenalectomy (RA) [3–5] These
excellent clinical achievements are valid for treatment of
small benign masses (< 5–6 cm), instead there are still open
questions in literature regarding the correct management
of larger lesions (> 6 cm) or in case of potentially malignant
adrenal tumors [6]. In these patients increases the risk of
incomplete resection, capsular disruption, local recurrence
and peritoneal dissemination [7].With the enlarged diffu-
sion of laparoscopy many surgeons carry out LA even if
they have poor experience with adrenal pathologies. On the
basis of these considerations, the aim of this study is to
evaluate the outcomes of LA in a referral surgical depart-
ment for endocrine surgery.
Methods
In our Department of General and Emergency Surgery
at the University Hospital Policlinico “P. Giaccone” of
Palermo between January 2010 and December 2017 we
performed a total of 81 LA. We created a retrospective
database with analysis of patients demographic data,
previous abdominal surgery, American Society of Anes-
thesiologists (ASA) score, morphologic and hormonal
characteristics of adrenal lesions, surgical procedures,
postoperative results, histological diagnosis and in par-
ticular cases also mid- and long-term follow-up. Only
patients with certain primary elements of malignant ad-
renal neoplasm on radiological examination like local
invasion and/or distant metastases were excluded from
the study because underwent to OA [8]. All surgical
procedures were performed by the same surgical team
experienced in endocrine and laparoscopic surgery in
order to obtain a standard technique.
Preoperative evaluation
Before surgery all patients underwent a complete preopera-
tive checkup including cardiological counseling for evaluat-
ing general performance status and endocrine study with
complete hormonal tests to identify functioning adrenal tu-
mors. Today there is no consensus on the optimal diagnos-
tic approach to the incidentally discovered adrenal masses.
For the diagnosis of Cushing’s syndrome we carried out
urine free cortisol test, serum cortisol and ACTH at 8 a.m.
and 6 p.m. (ACTH drawn into an EDTA tube, cooled). We
also used dexamethasone suppression test with evaluation
of cortisol secretion suppression after oral administration of
1mg dexamethasone at 11–12 p.m. The cortisol serum
concentration was measured on the following day in the
morning after overnight fasting (at 8–9 a.m.). In case of
aldosteronoma we dosed aldosterone serum concentration
and plasma renin activity (PRA) in upright position as in-
direct indicator of renin secretion. In our experience we did
not perform adrenal venous sampling to discern between
unilateral and bilateral aldosterone overproduction because
we had no cases of bilateral lesions. We examined the
adrenal medullary function with dosage of fractionated
urinary metanephrines and catecholamines using High Per-
formance Liquid Chromatography (HPLC) technique. With
the same HPLC we tested dehydroepiandrosterone (DHEA)
and dehydroepiandrosterone sulphate (DHEA-S) in patients
with hyperandrogenism. In order to obtain blood pressure
stabilization a pharmacological preoperative treatment was
done by alpha-1 blocker or calcic inhibitors in case of pheo-
cromocytoma (PCC); we used spironolactone and potas-
sium for Conn’s syndrome. In all cases we administered
antithrombotic and antibiotic prophylaxis. We carried out
routinely an abdominal contrast-enhanced Computed tom-
ography (CT) scan to study the morphological characteris-
tics and size of the lesion. Abdominal magnetic resonance
imaging (MRI) was used in selected patients with un-
clear features to the CT scan. We analyzed the presence
of fat components within the lesions through frequency
selective fat suppression and chemical shift suppression
or differences in cellularity on T1 and T2 weighted se-
quences [8]. We used functional imaging as [75se]cho-
lesterol, [131I]metaiodobenzylguanidine scintigraphy or
[18F]fluorodeoxyglucose positron emission tomography
(FDG-PET) only if necessary such as in case of bilateral
secreting lesions. A diagnosis of adrenal cortical carcin-
oma (ACC) was based on the patients history (e.g. hor-
monal symptoms with virilizing tumor) and radiologic
findings. We excluded from this study patients with im-
aging features of malignancy as local infiltration of the
surrounding structures, venous invasion or systemic
metastasis. In these cases we performed OA. In addic-
tion we also excluded from the study a right LA for
large bleeding angiomyolipoma performed in urgent
setting. The mere size of the lesion was not considered
a signal of malignant lesion [9]. Indication for LA
included hormone secreting tumors (Cushing’s lesion,
Conn’s syndrome, pheochromocytomas) and all non-
functioning tumors larger than 4 cm.
Surgical procedure
LA was carried out with a transperitoneal approach with
the patient in the lateral decubitus position with an
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inclination of 50–60° relative to the operating table
which was broken to extend the space between the last
rib and the iliac crest [10]. We always used Veress
needle to induce pneumoperitoneum also in case of pre-
vious abdominal surgery. For right adrenalectomy we
positioned four trocars in the right subcostal region. The
right lobe of the liver was mobilized by division of
triangular and coronary ligament to expose the adrenal
loggia. Then the posterior peritoneum overlying the
right adrenal gland, in Albarran-Chatelin space, was dis-
sected using Harmonic scalpel™ (Ethicon Endo Surgery
INC - Johnson & Johnson, NJ, USA). The tissue dissection
began along the lateral border of the inferior vena cava:
we used right renal vein as anatomic landmark and then
we identified a short adrenal vein that was clipped and di-
vided. After vascular ligation we reached the ileopsoas
muscle plane and the adrenal gland was mobilized until it
was completely free. For left-side adrenal resection we po-
sitioned three trocars in the left subcostal region. The
procedure began with adequate mobilization of splenic
flexure of the colon and then we divided splenocolic and
splenophrenic ligament to medially mobilize the splenic-
pancreatic block. On the contrary of the right side where
we had a well defined Albarran-Chatelin space, for the left
side the landmarks were more difficult to identify. We
could consider a quadrilater between spleen and pancre-
atic tail, upper pole of the kidney, left renal vein and ileo-
psoas muscle. The peritoneal dissection was done from
up-to-down until the left renal vein was reached and from
this we identified adrenal vein that was clipped and di-
vided. In some cases we used the diaphragmatic vein as
landmarks. Completed the vascular dissection the resec-
tion proceeded as previously described for the right ad-
renal gland on the posterior muscular plane from upper
pole of the kidney to the diaphragm with the aim to empty
the adrenal loggia. On the left side we always used Tis-
seel™ (Baxter International Inc. - Deerfield, Illinois, USA)
for repositioning splenic-pancreatic block in order to
avoid wandering spleen. At the end of the procedure sur-
gical specimens were positioned in endo-bag and removed
through the operative trocar or in case of large lesions
with sovrapubic mini-laparotomy to improve cosmesis
and prevent incisional hernia [11, 12]. The total operative
time, the partial surgical times (exposure of the adrenal
loggia, identification of the adrenal vein, dissection time)
and intraoperative complications were noted respectively
in the operative report and in the video recordings of the
procedure.
Postoperative management
Postoperative pharmacological management changed ac-
cording to the hormonal diagnosis of the adrenal mass.
In all patients normal diet and mobilization started on
the first postoperative day. We positioned abdominal
drainage only in large adrenal masses and difficult surgi-
cal procedures. In these cases drainage was removed on
the first or second postoperative day. Postoperative
complications, defined as an unexpected postoperative
course, were graded according to the Dindo-Clavien
classification [13]. For statistical analysis we only consid-
ered postoperative medical or surgical complications
with grade equal or superior to 2.
Statistical analysis
Statistical analysis were performed with SPSS 20.0
(SPSS Inc., Arlington, Virginia). Continuous variable
was expressed as the mean. Categorical Data were com-
pared with Chi-square analysis and continous data with
Student t test. A p value < 0.05 was considered statisti-
cally significant.
Results
Between January 2010 and December 2017, 81 patients
(34 male and 47 female) with a mean age of 55.4 years
(range 38–81) underwent to LA, 50 on the right side
and 31 on the left side. We did not treat bilateral lesions.
Patients and tumors characteristics are summarized in
Table 1. We registered that the major part of patients
(73 cases) had ASA score 3 with several comorbidities.
In 23 cases (28.4%) we found previous abdominal or
retroperitoneal surgery including 9 (11.1%) appendecto-
mies, 10 (12,3%) gynecological procedure and 4 (4.9%)
different surgeries (2 laparoscopic cholecystectomies, 1
open right hemicolectomy for cancer and 1 open surgi-
cal procedure for renal stones) [14]. Indications for LA
included 18 (22.2%) Cushing’s syndrome, 10 (12.3%)
Conn’s syndrome, 14 (17.3%) pheochromocytomas, 1
(1.2%) adrenal metastasis, 2 (2.5%) adrenocortical carcin-
omas (ACC), 17 (21%) non-secreting adenomas, 11
(13.6%) myelolipomas, 3 (3.7%) adrenal cysts, 4 (4.9%)
hemangiomas and 1 (1.2%) nodular hyperplasia [15].
Histological examination showed inside the Cushing’s
syndrome 2 adrenal cortical carcinomas. Inside the 14
pheochromocytomas 2 were malignant. We also found a
cystic pheochromocytoma with histological signs of ma-
lignancy in a patients with preoperative diagnosis of ad-
renal cyst. The lesion diagnosed as metastasis in patient
with history of endometrial cancer was really primary
ACC (Table 2).
Details of procedure are reported in Table 3. Mean size of
adrenal neoplasm was 7,5 cm (range 1.5 to 18 cm). Aldos-
teronoma was associated with the smallest size (1.5 cm)
while myelolipoma was the largest observed mass (18 cm).
The mean operative time was 145min (range 75–240). In
statistical analysis lenght of surgery was correlated to the
lesion diameter (p < 0.05) but not with pre-operative fea-
tures or histological results. With evaluation of the video
recordings of the surgical procedures we also took into
Di Buono et al. BMC Surgery 2019, 18(Suppl 1):128 Page 3 of 7
consideration the partial operative times: exposure of the
adrenal loggia, identification of the adrenal vein and dissec-
tion time. The results showed that in the functioning
masses and in particular in pheochromocytomas was
greater the time of identification of the adrenal vein. In the
large adrenal masses (> 6 cm) all three partial times were
increased but above all the adequate exposure of the ad-
renal loggia. 5 (6.2%) intraoperative complications occurred.
Among these patients 4 presented bleeding: 1 vena cava in-
jury treated with intracorporeal sutures and positioning of
pre-rolled TachoSil®; 1 from a small hepatic accessory vein
that was isolated and clipped; 1 caused from a spleen injury
during left adrenalectomy, in this case hemostasis was ob-
tained with use of hemostatic matrix (Floseal®); 1 from
peri-renal tissue solved by positioning of Hemopatch®. In
another patient with a large right adrenal masses (14 cm)
we observed a diaphagmatic lesion treated with suture and
intra-corporeal knotting with no transthoracic drainage [16,
17]. No conversion to open surgery was necessary and no
intraoperative blood transfusion were required. Mean esti-
mated blood loss was 95ml (range 50–350). Hemodynamic
change with intraoperative hypertension occurred in 2
cases during pheochromocitomas removal without particu-
lar complications. There was no capsular disruption during
adrenal dissection. There was none postoperative death.
According to the Dindo-Clavien classification [13] for stat-
istical analysis we only considered postoperative medical or
surgical complications with grade equal or superior to 2.
We excluded 4 cases of sovrapubic wound infections open
at the patient bedside (Grade 1). In one case we observed
wound hematoma that required postoperative blood trans-
fusion but not surgical intervention (Grade 2). In 3 patients
was necessary prolonged antibiotic intake after hospital dis-
charge due to localized pneumonia (Grade 2) None patient
underwent a reoperation due to complications (Grade 3).
In the statistical analysis there was no significant correlation
between mean tumor size, histological type, intraoperative
complication and postoperative outcome (p value > 0.05).
Only mean operative time resulted significant longer in
large adrenal tumors (> 6 cm). Mean length of hospital stay
was 3.7 days (range 3–6 days). Mean follow up was 38.5
Table 1 Demographic characteristcs of patients and indications
for surgery
Mean; n (%)
Sex (M/F) 34/47 (42%/58%)







- appendectomies 9 (11.1%)
- gynecological surgery 10 (12.3%)
- other procedures 4 (5%)
Pre-operative diagnosis
- Cushing’s syndrome 18 (22.2%)
- Pheochromocytoma 14 (17.3%)
- Conn’s syndrome 10 (12.3%)
- Non-secreting adenoma 17 (21%)
- Myelolipoma 11 (13.6%)
- Adrenal cyst 3 (3.7%)
- Hemangioma 4 (4.9%)
- Nodular Hyperplasia 1 (1.2%)
- Adrenocortical carcinoma 2 (2.5%)
- Metastasis 1 (1.2%)
Table 2 Histological diagnosis
n (%)
Cortisol-producing adenoma 16 (19.7%)
Pheochromocytoma 12 (14.8%)
Aldosterone-producing adenoma 10 (12.5%)
Non-functional adenoma 17 (21%)
Myelolipoma 11 (13.6%)
Adrenal cyst 2 (2.5%)
Hemangioma 4 (4.9%)
Nodular Hyperplasia 1 (1.2%)
Adrenocortical carcinoma 5 (6.2%)
Malignant Pheochromocytoma 3 (3.7%)
Metastasis –




- Right 50 (61.7%)
- Left 31 (38.3%)
- Bilateral –
Operative time 145min (range 75–240)
Lesion diameter 7.5 cm (range 1.5–18)
Conversion to open surgery –
Intraoperative complication
- Bleeding 3 (3.7%)
- Intraoperative blood transfusion –
- Organ lesion 2 (2.5%)
Postoperative complication
- Blood transfusion 1 (1.2%)
- Respiratory disease 3 (3.7%)
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months (range 3–72months). All patients with malignant
pheochromocytoma and adrenal cortical cancer were still
alive after mean follow-up of 26,2months (range 2–70). No
local recurrence and port-side metastasis was noted.
Discussion
Since 1992 LA has become the standard treatment in pa-
tients with small benign adrenal masses [1]. When com-
paring with open technique, LA offered better clinical
outcomes, reduced surgical trauma, lower perioperative
morbidity and mortality, shorten hospitalization and bet-
ter cosmetic results [2]. In order to reduce surgical trauma
and improvement clinical postoperative outcome several
authors developed posterior retroperitoneoscopic adrenal-
ectomy (PRA). A randomized clinical trial by Barczynski
et al. [18] showed excellent results of both techniques, an-
terior and posterior, in unilateral small tumors with statis-
tically significant advantage of PRA in operative time,
blood loss and postoperative course. However, the retro-
peritoneal approach reduced its benefits in the case of lar-
ger adrenal masses, so this approach could be preferred
for bilateral small lesions and for patients with multiple
past abdominal surgery that increased the risk of intraop-
erative complications and rate of conversion to the open
surgery [19]. Laparoscopic surgery was also more difficult
to learn than open surgery because required different psy-
chomotor skills. Robotic adrenalectomy (RA) presented
multiple advantages with three-dimensional vision and
increased degrees of freedom of the surgical instruments.
A recent meta-analysis [20] that included 798 patients
compared operative parameters and clinical outcomes be-
tween RA and LA. The authors concluded that RA was a
safe and feasible technique with reduced blood loss and
shorter hospital stay than LA. Laparoscopic approach
seemed to be a more rapid technique when comparing to
RA. On the other hand, some authors considered the use
of 3D laparoscopic technology with a traditional transperi-
toneal approach so as to combine the advantages of a
standardized and diffused surgical procedure with an
improved vision [21]. These authors analyzed LA for par-
ticular deep location of adrenal loggia with theoretical
maximum advantage of a 3D system. The results showed
the better visualization in depth perception with effect on
surgical precision but without significant differences in
term of operative time and intraoperative complications
[22, 23]. In our study we registered pre-operative data like
ASA score, radiological features and hormonal tests. In lit-
erature age and ASA score were direct related to in-
creased of length of hospital stay and postoperative
complications [24]. Radiological features and tumor size
appeared as a very important predictive parameter of out-
come. The results showed the large adrenal masses (> 6
cm) were associated with duration of surgery and with an
increased risk of intraoperative incident. Many author
reported lesion diameter over 5–6 cm as independent
predictive factors for conversion [25, 26]. Functioning
masses and in particular pheochromocytomas required
longer operative time to identify the adrenal vein but
these differences were no statistically significant. From
analysis of partial operative time we also demonstrated
that in large adrenal masses significantly increased the
time necessary to approach the adrenal loggia. First ex-
posure of adrenal gland by section of triangular and
coronary liver ligament on the right side and splenoco-
lic and splenophrenic ligament on the left side must be
performed carefully in order not to damage diaphragm,
spleen and pancreatic tail. Bleeding was the main intra-
operative complications and injuries of the vena cava,
renal vein or hepatic vein represented a real dangerous
situation with increased conversion rate [27].We did
not report conversion to open surgery. In case of intra-
operative complications we performed a conservative
laparoscopic management of vascular, splenic and dia-
phragmatic injuries. The conversion instead was mandatory
in case of intraoperative evidences of malignancy like peria-
drenal tissue infiltration or vascular invasion. We consid-
ered capsular disruption as an intraoperative complication
too. Literature data suggested that the main limitation dur-
ing laparoscopic dissection for large and potentially malign
adrenal tumors was incomplete resection and capsular dis-
ruption with increased risk of local recurrence and intra-ab-
dominal neoplastic dissemination [28], but the tumor size
per se could not be considered as an absolute controindica-
tion to LA. A correct preoperative patients selection and a
meticulous surgical technique could limit that risk. Postop-
erative complication rate was 5% with one blood transfu-
sion and three respiratory diseases. According to Dindo-
Clavien scale rate we considered medical or surgical com-
plications with grade ≥ 2 for statistical analysis with no
significant correlation between mean tumor size, histo-
logical type and postoperative outcome (p value > 0.05).
Coste T. et al. [24] reported that postoperative medical
complications were mainly respiratory diseases and various
infections.
Conclusion
In this study we used retrospective data like demo-
graphic, radiological and hormonal characteristics and
prospective parameters such as partial time of surgical
procedures and evaluation of intraoperative complica-
tions obtain from recordings video of LA. The study
period was limited from January 2010 to December 2017
and the all procedures were performed in a single center
by an experienced endocrine and laparoscopic surgical
team. The limitations were related to lower rate of post-
operative complication with not significant results in
terms of association between preoperative characteristics
and postoperative outcomes. Nevertheless, it is possible
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to confirm that LA is a safe procedure with low rate of
morbidity. An accurate preoperative radiological examin-
ation is fundamental to obtain a stringent patients selec-
tion. The lesion diameter is related to longer operative
time and appeares as the main predictive parameter of in-
traoperative complications but these results are not statis-
tically significant. On the other side secreting adrenal
tumors require more attention in operative management
without increased rate of postoperative complications.
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